Product Information
FLUTICASONE-SALMETEROL 113-14 is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $111.5128 per EA under NDC 00093360882. Its NADAC has been published 457 times since Nov 22, 2017.
FDA first approved this application on Jan 27, 2017.
Strength
113; 14 ug/1; ug/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093360882
Classification
Generic
Dosage Form
POWDER, METERED
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA208799FDA Approved
1/27/2017
On Market Since
4/28/2017
Pharmacological Classes
Price Statistics
The NADAC for FLUTICASONE-SALMETEROL 113-14 has been published 457 times since Nov 22, 2017, and over the history we have for it it has risen 30.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $111.5128 per EA |
|---|---|
| All-time high | $114.4698 (Jun 10, 2026) |
| All-time low | $80.9689 (Apr 21, 2021) |
| 52-week high | $114.4698 |
| 52-week low | $104.2930 |
| Median price | $91.1632 |
| Average price | $95.7574 |
| Largest weekly change | +17.1% (Apr 20, 2022) |
| Weeks tracked | 457 |
| Tracking since | Nov 22, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FLUTICASONE-SALMETEROL 113-14?
The current National Average Drug Acquisition Cost (NADAC) for FLUTICASONE-SALMETEROL 113-14, manufactured by Teva Pharmaceuticals USA Inc., is $111.5128 per EA (NDC 00093360882), effective Aug 19, 2026.
How has the price of FLUTICASONE-SALMETEROL 113-14 changed over time?
Over the history we have for it, the NADAC for FLUTICASONE-SALMETEROL 113-14 has risen 30.4%. It has been tracked across 457 weekly CMS publications since Nov 22, 2017.
What are the highest and lowest recorded NADAC prices for FLUTICASONE-SALMETEROL 113-14?
Since Nov 22, 2017, the NADAC for FLUTICASONE-SALMETEROL 113-14 has ranged from a low of $80.9689 (Apr 21, 2021) to a high of $114.4698 (Jun 10, 2026), with a median of $91.1632 per EA.
Are there cheaper alternatives to FLUTICASONE-SALMETEROL 113-14?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FLUTICASONE-SALMETEROL 113-14 in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUTICASONE-SALMETEROL 113-14?
FLUTICASONE-SALMETEROL 113-14 (NDC 00093360882) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.